Table 1 Basic information of pregnant women in the four groups(%).

From: Clinical study of single nucleotide polymorphism-based chromosome microarray analysis in the etiological diagnosis of fetal congenital heart disease

Variable

Isolated CHD group

Non-isolated CHD group

Non-CHD group

Normal group

χ2/Fisher

P-Vale

n

237

136

1632

3111

  

Number of pregnancies

      

1

93(39.24)

45(33.09)

564(34.56)

674(21.66)

131.61

< 0.001

2

58(24.47)

47(34.56)

477(29.23)

922(29.64)

  

≥ 3

86(36.29)

44(32.35)

591(36.21)

1515(48.70)

  

Number of births

      

0

133(56.12)

68(50.00)

791(48.47)

1107(35.58)

110.01

< 0.001

1

93(39.24)

55(40.44)

711(43.57)

1627(52.30)

  

2

10(4.22)

11(8.09)

119(7.29)

341(10.96)

  

≥ 3

1(0.42)

2(1.47)

11(0.67)

36(1.16)

  

High risk factor

      

Yes

75(31.65)

44(32.35)

417(25.55)

1996(64.16)

688.108

< 0.001

No

162(68.35)

92(67.65)

1215(74.45)

1115(35.84)

  

Types of risk factors

      

Advanced age

43(18.14)

24(17.65)

324(19.85)

1119(35.97)

159.47

< 0.001

History of adverse pregnancy

37(15.61)

18(13.24)

76(4.66)

563(18.10)

165.81

< 0.001

Noninvasive DNA is high risk

7(2.95)

7(5.15)

63(3.86)

667(21.44)

306.28

< 0.001

One of the couples has a chromosomal abnormality

2(0.84)

0(0.00)

6(0.37)

54(1.74)

19.87

< 0.001

Variable

Isolated CHD group

Non-isolated CHD group

Normal group

χ2/Fisher

P-Vale

N

237

136

3111

  

Aneuploidies

9(3.80)

23(16.91)

240(7.71)

20.99

< 0.001

pathogenic CNVs

5(2.11)

5(3.68)

83(2.67)

0.93

0.60

22q11.2

5(2.11)

1(0.74)

11(0.35)

16.961

< 0.001

Others

0(0.00)

4(2.94)

72(2.31)

  

likely pathogenic CNVs

0(0.0)

0(0.0)

10(0.32)

0.037

1.00

pathogenic and likely pathogenic CNVs

14(5.91)

28(20.59)

411(13.21)

17.59

< 0.001

variation unknown significance CNVs

9(3.80)

6(4.41)

181(5.82)

2.09

0.35